Other substances

LMG_1552174

A protease inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

LMG_1552174 is a putative SARS-CoV-2 Papain-like protease inhibitor (Alamri et al., 2020).

Synonyms

(N-(2-(3H-pyrazol-4-yl)ethyl)-4-((3-(2-fluorophenyl)isoxazol-5-yl)methyl)tetrahydro-2H-pyran-4-carboxamide)

 

O=C(NCCC1=CN=NC1)C4(Cc3cc(c2ccccc2F)no3)CCOCC4

Supporting references

Link Tested on Impact factor Notes Publication date
Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
PapainLpro Small molecule In silico 		in silico 2.67

Predicted to inhibit the SARS-CoV-2 Papain-like protease. 

 Aug/28/2020
Export (.csv)